Agne Paner

Director of Multiple Myeloma and Amyloidosis program at Rush University Medical Center

[Phari @Phari]

T cell Therapy in MM goes beyond CART - @MCWCancerCenter @MCW_Research @bhemato @SChhabra_MCW @adsouza_md @MeeraMohanMD

[Agne Paner @PanerAgne]

Perfect proof that little knowledge is dangerous. Very sad how freedom of speech can be misused when there is no accountability for what one says in public.

[James Hoffman @Drjhoffmanmiami]

Criminal. Myeloma patients often not protected by 2 shots- that’s why he was planned for a booster. This is known fact. Here you have a person w an audience using Colin Powell’s death to make an anti vax PSA. He should be ashamed of himself, but he won’t be.

[Agne Paner @PanerAgne]

I look forward to learn from real case discusions from myeloma experts

[Suzanne Lentzsch, MD, PhD @SLentzsch]

Please join Multiple Myeloma Rounds presented by @rajshekharucms and @dikokaz September 14th, 2021 6:30-8:15PM. Registration: https://t.co/7cdaPnzV9I @PleXusComm @DrOlaLandgren

[. @IreneGhobrial]

Going for a run in the morning with my ⁦@PromiseStudy⁩ shirt. A woman stopped me because her mom and other family have myeloma. She wants to screen. ⁦@PromiseStudy⁩ #mmsm

[Suzanne Lentzsch, MD, PhD @SLentzsch]

Please see the CDC recommendation on tightly fitted 😷. Below are easy options to make sure that your mask fits tightly to your face ➡️try knotted ear loops and tucked-in sides of you surgical mask

[Dr. Jeffrey Zonder @Amyloid_Planet]

@adsouza_md @AmyloidosisSupp @MorieGertz @PanerAgne About 350 participants on right now listening to a presentation about amyloid imaging by Dr Wall at U of Tennessee

[Agne Paner @PanerAgne]

Vital statistics

[Luciano J Costa @End_myeloma]

Anaphylaxis with #COVID19 vaccine 1:265,000. ZERO deaths.
Dying in car crash in US 1:5,000 /y
Being struck by lightning in lifetime 1:3,000

15 min observation-> 66,381 h (91 mo!)of productivity wasted per anaphylaxis episode (do the math). Necessary?

https://t.co/eVMW8guhBo

[Mia Levy, MD, PhD @DrMiaLevy]

As access to the #COVIDVaccines widens, it's important to have all the facts in order to make an informed decision, particularly if you have a history of cancer. @RushCancer, we have provided this resource to help answer any lingering questions. https://t.co/2HrYy8Uczr

[Agne Paner @PanerAgne]

Great resource from ASH for quick answers to important questions

[ASH @ASH_hematology]

We have updated our #COVID19 FAQs to give you the most up-to-date information, including new items about the vaccines with #EmergencyUseAuthorization and vaccines and immunocompromised patients. #ASHCOVID

Read them now: https://t.co/j0VrMMH2q2

[Agne Paner @PanerAgne]

@AjayNookaMD @WinshipAtEmory @kaufman_MMdoc Start teaching those birds to fly - hang paintings on walls😄 lovely! Thanks for sharing the goodness

[Agne Paner @PanerAgne]

Very well thought through😁😆

[Luciano J Costa @End_myeloma]

Found this practical tool to decide if one should get the #COVID vaccine

[Agne Paner @PanerAgne]

@End_myeloma Hillarious😁😆

[Agne Paner @PanerAgne]

@DrOlaLandgren This such a historic moment. Makes my heart tremble.

[C. Ola Landgren, M.D. @DrOlaLandgren]

First trucks carrying the COVID-19 vaccine in the US have left the Pfizer facility https://t.co/oVgjGsbbgT

[Suzanne Lentzsch, MD, PhD @SLentzsch]

DCdP vs Dcd with Pom added in case of PD presented by 👏@MichaelSebag on behalf of @ResearchMyeloma. Quadruplets achieve high OR 88.6% in RRMM, Pom can be added at time of PD as the PSF shows NS difference. I favour the quadruplets from the start #ASH20 #ASH20SL #mmsm

[ASH @ASH_hematology]

👍Give us a thumbs up if you're watching Dr. Fauci and @StephanieLeeMD right now! #ASH20 #ASHCOVID

[Suzanne Lentzsch, MD, PhD @SLentzsch]

Phase 3 TOURMALINE-MM2: IRd Vs Rd for non-ACST NDMM by Thierry Facon
➡️No significant difference in PFS and OS
➡️but⬆️PFS by 13.5 mos for IRD
➡️VGPR 63 vs 47.7%
DRd is the winner but IRD still better than RD bacuse of meaningful clinical benefit #ASH20 #ASH20SL #mmsm

[Suzanne Lentzsch, MD, PhD @SLentzsch]

My favorite topic #amyloidosis: Update on Andromeda Dara-CyBorD vs CyBorD by Ray Comenzo
➡️Dara-CyBorD results in longer PFS
➡️Dara-CyBorD significantly delays organ deterioration
Dara-CyBorD is clearly the new SOC in AL! But is Dara maintenance also the new SOC? #ASH20 #ASH20SL

[Suzanne Lentzsch, MD, PhD @SLentzsch]

Congratulations @moderna_tx Another promising mRNA vaccine against #COVID19!

[C. Ola Landgren, M.D. @DrOlaLandgren]

The Annual Myeloma MRD meeting has evolved from a “local” NYC meeting with 20-30 people back in 2014 -> today we had 400 participants worldwide! Excellent presentations & forward looking debates and discussions. Thank you all for working together & sharing your knowledge! #mmsm